JPMorgan Chase & Co. Issues Pessimistic Forecast for Vertex ...

4 days ago · JPMorgan Chase & Co. lowered their target price on shares of Vertex Pharmaceuticals from $503.00 to $500.00 and set an "overweight" rating on the stock in a …

$503.00
OFF

JPMorgan Chase & Co. Issues Pessimistic Forecast For Vertex ...

2 days from now

4 days ago · JPMorgan Chase & Co. lowered their target price on shares of Vertex Pharmaceuticals from $503.00 to $500.00 and set an "overweight" rating on the stock in a …

marketbeat.com

$510.00
OFF

JPMorgan Chase & Co. Issues Pessimistic Forecast For Vertex ...

2 days from now

Nov 7, 2024 · Vertex Pharmaceuticals (NASDAQ:VRTX – Get Free Report) had its price target dropped by stock analysts at JPMorgan Chase & Co. from $510.00 to $503.00 in a research …

americanbankingnews.com

$510.00
OFF

JPMorgan Chase & Co. Issues Pessimistic Forecast For Vertex ...

2 days from now

Nov 7, 2024 · Vertex Pharmaceuticals (NASDAQ:VRTX – Get Free Report) had its price target reduced by JPMorgan Chase & Co. from $510.00 to $503.00 in a research report issued on …

defenseworld.net

$510.00
OFF

Bank Of America Issues Pessimistic Forecast For Vertex …

2 days from now

Dec 21, 2024 · Finally, JPMorgan Chase & Co. dropped their price target on Vertex Pharmaceuticals from $510.00 to $503.00 and set an “overweight” rating on the stock in a …

defenseworld.net

$170.00
OFF

JPMorgan Chase & Co. Issues Pessimistic Forecast For Science ...

2 days from now

Dec 7, 2024 · Science Applications International (NYSE:SAIC - Free Report) had its target price decreased by JPMorgan Chase & Co. from $170.00 to $148.00 in a report issued on Friday …

marketbeat.com

$8.50
OFF

JPMorgan Chase & Co. Issues Pessimistic Forecast For Inter & Co, …

2 days from now

Dec 13, 2024 · Inter & Co, Inc. (NASDAQ:INTR - Get Free Report) had its target price decreased by investment analysts at JPMorgan Chase & Co. from $8.50 to $7.20 in a research note …

marketbeat.com

$97.00
OFF

JPMorgan Chase & Co. Issues Pessimistic Forecast For Dollar …

2 days from now

Nov 5, 2024 · JPMorgan Chase & Co. cut their target price on Dollar General from $97.00 to $82.00 and set a "neutral" rating on the stock in a research note on Tuesday. ... JPMorgan …

marketbeat.com

$16.00
OFF

JPMorgan Chase & Co. Issues Pessimistic Forecast For Dana …

2 days from now

Nov 12, 2024 · Dana (NYSE:DAN – Free Report) had its target price reduced by JPMorgan Chase & Co. from $16.00 to $14.00 in a research report sent to investors on …

mayfieldrecorder.com

$5.56
OFF

JPMorgan Chase & Co. Issues Pessimistic Forecast For Schroders …

2 days from now

Nov 9, 2024 · Schroders (LON:SDR – Get Free Report) had its price target dropped by stock analysts at JPMorgan Chase & Co. from GBX 427 ($5.56) to GBX 407 ($5.30) in a research …

defenseworld.net

$100.53
OFF

Bank Of America Issues Pessimistic Forecast For Vertex

2 days from now

Dec 19, 2024 · The stock has a market cap of $100.53 billion, a P/E ratio of -196.17 and a beta of 0.36. Vertex Pharmaceuticals has a 52-week low of $377.85 and a 52-week high of $519.88. …

marketbeat.com

$16.00
OFF

JPMorgan Chase & Co. Issues Pessimistic Forecast For Dana

2 days from now

Nov 11, 2024 · Dana (NYSE:DAN – Get Free Report) had its price objective reduced by investment analysts at JPMorgan Chase & Co. from $16.00 to $14.00 in a report released on …

techdows.com

59%
OFF

Okta (NASDAQ:OKTA) Price Target Cut To $85.00 By Analysts At …

2 days from now

Nov 30, 2024 · JPMorgan Chase & Co.'s price objective would suggest a potential upside of 9.59% from the company's previous close. Get Okta alerts: Sign Up. Several other equities …

marketbeat.com

FAQs about JPMorgan Chase & Co. Issues Pessimistic Forecast for Vertex ... Coupon?

Does JPMorgan Chase & Co hold a pessimistic view on the stock market?

JPMorgan Chase & Co. continues to hold one of the most pessimistic views on Wall Street regarding the U.S. stock market, expecting a decline in the coming months despite the S&P 500 reaching new all-time highs in June. ...

Should you buy JPMorgan Chase (JPM) stock?

The average analyst rating for JPMorgan Chase stock from 17 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months. Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP. Sources: Price targets and analyst ratings provided by Benzinga. ...

What are JPMorgan's S&P 500 forecasts for 2024?

Notably, JPMorgan’s S&P 500 forecasts for 2024 have not changed since the world’s largest investment bank issued its market outlook in late 2023. Analysts at JPMorgan forecast the S&P 500 — as tracked by the SPDR S&P 500 ETF Trust (NYSE:SPY) — ending the year at 4,200 points, implying a 22% drop from current levels. ...

Does Vertex Pharmaceuticals outperform Zacks medical - biomedical and genetics?

Shares of Vertex Pharmaceuticals have outperformed the Zacks Medical - Biomedical and Genetics industry over the past year (+49.7% vs. -6.1%). The company's cystic franchise sales continue to grow, driven by its triple therapy, Trikafta/Kaftrio. ...